Phase I Multiple-Ascending Dose (Japan) (MAD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00538174
First received: October 1, 2007
Last updated: March 20, 2015
Last verified: March 2015